Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-4,025
Closed -$339K 173
2020
Q3
$339K Sell
4,025
-146
-4% -$11.4K 0.14% 139
2020
Q2
$271K Buy
4,171
+294
+8% +$19.4K 0.12% 138
2020
Q1
$252K Buy
3,877
+508
+15% +$40K 0.14% 131
2019
Q4
$265K Buy
3,369
+190
+6% +$14.8K 0.11% 141
2019
Q3
$253K Buy
3,179
+481
+18% +$37.8K 0.11% 138
2019
Q2
$226K Buy
+2,698
New +$215K 0.1% 139
2015
Q2
$8K Buy
+220
New +$8K 0.01% 297

Other funds holding XYL

FMA Advisory's XYL Position: Q4 2020 in Review

FMA Advisory sold out of Xylem (XYL) in Q4 2020, closing a stake of 4,025 shares — an estimated $339K sold.

FMA Advisory first reported a position in XYL in Q2 2015 and held it in 7 quarters. The position peaked at $339K in Q3 2020. 732 funds tracked by Wall St. Rank hold XYL as of Q4 2020.

  • FMA Advisory reported no remaining Xylem position as of Q4 2020 after selling out during the quarter.
  • FMA Advisory sold 4,025 Xylem shares in Q4 2020, an estimated $339K.
  • FMA Advisory first reported a position in Xylem in Q2 2015 and held it in 7 quarters.
  • FMA Advisory's Xylem position peaked at $339K in Q3 2020.
  • 732 funds tracked by Wall St. Rank held Xylem as of Q4 2020.

Based on FMA Advisory's 13F filing for Q4 2020, filed 12 Apr 2021.